Home > Insider Trading > Filing (0001455244-10-000149)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Nabi Biopharmaceuticals	NABI	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376960	Jason Aryeh	34 Summer Rd. Greenwich CT 06831		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-12-15	1,907	$5.74	15,093	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	164,783	Indirect	Indirect

Footnotes

On December 17, 2010, a Form 4 was filed on behalf of the reporting person that incorrectly reported the form of ownership of certain securities sold by the reporting person. The transaction reported on the original Form 4 indicated that the shares sold were indirectly owned by the reporting person. The shares sold were owned directly by the reporting person.
Consists of shares benefically owned by Jason Aryeh through his relationship with JALAA Equities, LP, the Jason Aryeh Trust, the Jason Aryeh 2003 Family Trust, and the Jason Aryeh IRA (collectively, the "Aryeh Entities"). Mr. Aryeh disclaims beneficial ownership of all securities held through the Aryeh Entities, except to the extent of any indirect pecuniary interest he may have therein.